Tel. : 01 45 33 67 17 / E-mail : coger@coger.fr
AVANTI POLAR LIPIDS , CYGNUS , LARODAN , ADIPOGEN , MYBIOSOURCE , SERVA NORDMARK, BIOWORLD, EDGEBIO , PANREAC APPLICHEM
Ajouter au panier
Le produit a été ajouté au panier Le stock est insuffisant. unités ont été rajoutées au panier Total:
|
Stock épuisé.
En rupture de stock
|
Quantité minimum d'achat
La quantité minimum d'achat n'est pas atteinte
|
photos non contractuelles
Product description: Monoclonal Antibody. Recognizes the Human, Rat protein. Liquid. HEPES with 0.15M NaCl, 0.01% BSA, 0.03% sodium azide, and 50% glycerol. Cyclin D1 (Bcl-1 oncogene product), is a member of the Cyclin family that help control transition between phases of the cell cycle by acting as regulatory subunits of the Cdks. The D-type Cyclins are composed of three subtypes, Cyclin D1, D2 and D3. Cyclin D1 is essential for control of the cell cycle at the G1/S transitions and interacts with Cdk4 or Cdk6 protein kinases. On the recent study, Cyclin D1 regulates cellular metabolism, fat cell differentiation and cellular migration. Also Cyclin D1 involves in development and cancer. Essential for the control of the cell cycle at the G1/S (start) transition.
Alternate Names/Synonyms: BCL1; CCND1; BCL-1; BCL-1 Oncogene; PRAD1 Oncogene; G1/S-specific Cyclin-D1; B-Cell Lymphoma 1 Protein
Product Type: Monoclonal Antibody
Clone: AF2G5
Isotype: Mouse IgG1 kappa
Immunogen: Recombinant human His-Cyclin D1 protein purified from E. coli.
Applications: IP, WB
Species Crossreactivity: Human, Rat
Formulation: Liquid. HEPES with 0.15M NaCl, 0.01% BSA, 0.03% sodium azide, and 50% glycerol.
Short Term Storage: +4°C
Long Term Storage: -20°C
Shipping: BLUE ICE
Use & Stability: Stable for at least 1 year after receipt when stored at -20°C.
Literature References: 1) Toru Motokura et al. (1992) J Biol Chem 267(28):20412-20415. (General)2) Xiang Zhang et al. (2005) Journal of Clinical Neuroscience 12(2):166-168. (General)3) Sherr CJ, (1993) Cell 73:1059-1065. (General)4) Hirofumi Nakagami et al. (2002) The Plant Cell 14:1847-1857. (General)
Alerte
Veuillez saisir les champs obligatoires! |